Skip to content

Effect of Curodont in patients suffering white-spot-lesions after orthodontic treatment

Effect of Curodont in patients suffering white-spot-lesions after orthodontic treatment - SAP-study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
DRKS
Registry ID
DRKS00016501
Enrollment
25
Registered
2019-01-30
Start date
2013-09-16
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K02.0

Interventions

Group 1: Curodont Repair (monomeric P11-4) Group 2: Untreated control

Sponsors

Poliklinik für Zahnerhaltung, Parodontologie, Endodontologie, Präventive Zahnmedizin und Kinderzahnheilkunde im Zentrum für Zahn-, Mund- und Kieferheilkunde der Universitätsmedizin der Ernst-Moritz-Arndt Universität Greifswald
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 17 Years

Inclusion criteria

Inclusion criteria: White spot (demineralisation) lesions present after removal of fixed orthodontic appliances • Size and form of the lesion: The lesion must be fully visible and assessable and accessible. • Able and willing to observe good oral hygiene throughout the study • = 20 teeth and a BP score of < 3 • Age = 12 years and = 65 years • Willing and able to attend the on-study visits • Willing and able to understand all study-related procedures • Written informed consent before participation in the study

Exclusion criteria

Exclusion criteria: Pre-treated carious lesion • Tooth with other carious lesions apart from the ones developed during orthodontic treatment • Patient suffers from diabetes • Evidence of tooth erosion (due to excessive acidic drink consumption) • History of head and neck illnesses (e.g. head & neck cancer) • Any pathology or concomitant medication affecting salivary flow • Any metabolic disorders affecting bone turnover • Concurrent participation in another clinical trial with an investigational drug or device or participation in another clinical trial with an investigational drug or device within 30 days prior to study entry • Any skin diseases • Patient being pregnant • Patient having a pacemaker

Design outcomes

Secondary

MeasureTime frame
Morphometric measurements of WSL with Shadepilot/TM (DeguDent / Germany) (day 0, day 45, day 90, and day 180) for the assessment of the change of the caries extent on the tooth surface.

Primary

MeasureTime frame
Impedance measurements of WSL with CarieScan Pro/TM (orangedental / Germany) (day 0, day 45, day 90, and day 180) for assessment of the caries progression/Regression.

Countries

Germany

Contacts

Public ContactAlexander Welk

Poliklinik für Zahnerhaltung, Parodontologie, Endodontologie, Präventive Zahnmedizin und Kinderzahnheilkunde im Zentrum für Zahn-, Mund- und Kieferheilkunde der Universitätsmedizin der Greifswald

welk@uni-greifswald.de+49383487169

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026